Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience
Familial Cancer · 06.07.2026 · 25 (3)
DOI: 10.1007/s10689-026-00586-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 06.07.2026. Verfasst von Omar Salehi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Familial Cancer Clinic, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. Hauptthemen laut MEDLINE: Carcinoma, Signet Ring Cell, Stomach Neoplasms, Cadherins, Antigens, CD. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University.
Abstract (Originalsprache)
CDH1 pathogenic variant carriers are at high lifetime risk of hereditary diffuse gastric cancer (HDGC). Endoscopic surveillance is recommended for individuals who delay risk-reducing total gastrectomy, although detection of signet ring cell carcinoma (SRCC) remains challenging. No Australian cohort has reported real-world endoscopic performance with surgical correlation in this population. We performed a 15-year retrospective cohort study of adult CDH1 carriers undergoing esophagogastroduodenoscopy (EGD) at a tertiary familial cancer centre (2008–2023). Patients presenting with symptomatic invasive gastric cancer at initial endoscopy were excluded. Most EGDs were conducted as preoperative assessments prior to risk-reducing total gastrectomy, with a minority undertaken as longitudinal surveillance. Endoscopic findings, biopsy performance, surgical pathology, and postoperative outcomes were analysed. Eighty-two CDH1 carriers from 31 families underwent 136 EGDs (median 1 per patient). SRCC was detected endoscopically in 38 patients (46.3%), predominantly via random biopsies. Overall sensitivity for SRCC detection was 67.9%, with random biopsies outperforming targeted sampling. Most lesions were identified at the initial EGD. Sixty-nine patients (84.1%) proceeded to total gastrectomy; SRCC was confirmed in 56 (81.2%), with variable tumour burden (1–73 foci). Invasive disease beyond pT1a was uncommon (2.9%). Postoperative complications occurred in 43.5%, most frequently anastomotic strictures requiring dilatation; there were no procedure-related deaths. Although occult SRCC was common, invasive malignancy beyond pT1a was infrequent, suggesting that many intramucosal lesions may have a more indolent course than previously assumed. Detection of SRCC at endoscopy remains challenging; however, these findings support a more individualized, risk-adapted approach to CDH1 management. Longer-term prospective data are required to better define SRCC progression risk and guide decisions regarding surveillance and risk-reducing surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Familial Cancer Clinic, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.
- Department of Gastroenterology, Alfred Health, Melbourne, VIC, 3004, Australia.
- School of Translational Medicine, Monash University, Melbourne, 3004, Australia.
- Familial Cancer Clinic, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. alex.boussioutas@monash.edu.
- Department of Gastroenterology, Alfred Health, Melbourne, VIC, 3004, Australia. alex.boussioutas@monash.edu.
- School of Translational Medicine, Monash University, Melbourne, 3004, Australia. alex.boussioutas@monash.edu.
Förderung
- Monash University
Zitieren
APA
Salehi, O., Tjandra, D., Karp, J., & Boussioutas, A. (2026). Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience. Familial Cancer, 25(3). https://doi.org/10.1007/s10689-026-00586-9
Vancouver
Salehi O, Tjandra D, Karp J, Boussioutas A. Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience. Familial Cancer. 2026;25(3). doi:10.1007/s10689-026-00586-9
BibTeX
@article{Salehi2026,
author = {Salehi, Omar and Tjandra, Douglas and Karp, Jadon and Boussioutas, Alex},
title = {Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience},
journal = {Familial Cancer},
year = {2026},
volume = {25},
number = {3},
doi = {10.1007/s10689-026-00586-9}
}
EUVIMED